secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0000950170-24-009160
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Labs gets 180-day Nasdaq bid-price extension; faces delisting if not compliant by July 29, 2024
--------------------------------------------------------------------------------

- Nasdaq granted additional 180-day extension to July 29, 2024, to regain $1 minimum bid price compliance.
- Company previously failed minimum bid price based on 30 consecutive business day closing bid.
- If not compliant by deadline, Nasdaq will issue delisting notice; company may appeal.
- Company may implement reverse stock split to regain compliance but provides no assurance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017024009160/0000950170-24-009160-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017024009160/hscs-20240130.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-009160

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer